Daclatasvir/ribavirin/sofosbuvirLack of efficacy: case report

被引：0
作者：
机构：
来源：
Reactions Weekly | 2023年 / 1950卷 / 1期
关键词：
D O I：
10.1007/s40278-023-36545-7
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：148 / 148
相关论文
共 50 条
  • [31] Daclatasvir/ribavirin/simeprevirHyperuricaemia and development of daclatasvir resistance and simeprevir resistance in recurrent hepatitis C : 6 case reports
    Reactions Weekly, 2016, 1599 (1) : 79 - 79
  • [32] Sofosbuvir, ribavirin and pegylated interferon for a daclatasvir-resistent genotype 3 hepatitis C virus: case report and review
    Mucenic, Marcos
    de Melo Brandao, Ajacio Bandeira
    Marroni, Claudio Augusto
    Fleck Junior, Alfeu de Medeiros
    Zanotelli, Maria Lucia
    Leipnitz, Ian
    Meine, Mario Henrique
    Kiss, Guillermo
    Martini, Juliano
    Schlindwein, Eduardo Soares
    Costabeber, Ane Micheli
    Rodrigues Sacco, Fernanda Karlinsky
    Rossato, Giovana
    Cracco Cantisani, Guido Pio
    REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO, 2019, 61
  • [33] Daclatasvir/sofosbuvirExtensive skin rash: case report
    Reactions Weekly, 2018, 1683 (1) : 240 - 240
  • [34] Daclatasvir/sofosbuvirAcute interstitial nephritis: case report
    Reactions Weekly, 2017, 1666 (1) : 97 - 97
  • [35] The efficacy of sofosbuvir/velpatasvir/ribavirin in cirrhotic, genotype 3a HCV patients, previously failures to sofosbuvir/daclatasvir/ribavirin combination
    Dimitroulopoulos, D.
    Karatapanis, S.
    Kypreos, D.
    Malahias, A.
    Tsamakidis, K.
    Xinopoulos, D.
    JOURNAL OF VIRAL HEPATITIS, 2018, 25 : 71 - 71
  • [36] Safety and Efficacy of Sofosbuvir Plus Ribavirin and Sofosbuvir Plus Daclatasvir With or Without Ribavirin Combinations in Children and Adolescents With Chronic Hepatitis C
    Hassan, Adil
    Bughio, Ubedullah
    Bhatti, Rehmatullah
    Ali, Mashooque
    Jamali, Laraib
    Sadik, Muhammad
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S592 - S592
  • [37] Daclatasvir/sofosbuvirErythema multiforme drug eruption associated with erythrodermic psoriasis (first report with daclatasvir): case report
    Reactions Weekly, 2017, 1641 (1) : 103 - 103
  • [38] Daclatasvir/sofosbuvirElevated bilirubin levels: case report
    Reactions Weekly, 2018, 1692 (1) : 125 - 125
  • [39] Daclatasvir/sofosbuvirHepatic epithelioid haemangioendothelioma: case report
    Reactions Weekly, 2017, 1681 (1) : 126 - 126
  • [40] Daclatasvir/sofosbuvir/velpatasvirLack of efficacy : 3 case reports
    Reactions Weekly, 2024, 2018 (1) : 156 - 156
12345